  |
 |
|
|
| Adi M. Treasurywala, President
After obtaining his PhD in the synthesis of Natural Products at UBC (vinblastine) and a fruitful postdoctoral fellowship at the ETH Zurich, Adi joined Ayerst Laboratories in Montreal and was responsible for starting the first industrial computational chemistry group in Canada. In 1983 he moved with that company to Princeton New Jersey as the head of the computational chemistry group. At Ayerst, Adi became involved with projects in several different therapeutic areas and was responsible for the design of the anti-diabetic drug Tolrestat. Tolrestat is one of the early examples of a commercial substance that has evolved through the participation of computer-assisted molecular design. Dr. Treasurywala has served in various capacities at Ayerst Laboratories, Sterling Winthrop, Allelix Biopharmaceuticals Inc, and Pfizer and as the CEO of OncoDynamics Inc., Protagenic Therapeutics Inc., and CELLutions Biosystems Inc. For approximately 5 years, Dr. Treasurywala served as the Chief Operating Officer of the University of Toronto Innovations Foundation (UTIF) and simultaneously as Director of Business Development at the University of Toronto. He is currently the President of ArrowCan Partners Inc. He has served on the Board of Directors of the The Biotechnology Initiative (TBI) and Youth Science Ontario. In 2009 Adi was awarded the TBI Volunteer of the Year award in acknowledgement of his many volunteer activities with different organizations. He has over 25 years of experience in the Pharmaceutical Industry with a proven track record in establishing and leading multidisciplinary and multinational teams to success. Throughout his career, Dr. Treasurywala has retained a strong commitment to contributing to the success of the teams with which he has been associated. Mary-Rose Treasurywala, Partner
With a Master’s degree in Sociology and a specialization in Survey Research Mary-Rose brings a keen knowledge of the market research side of industry to ArrowCan Partners. After an honors BA from the University of Toronto she completed her graduate work at the University of British Columbia. Mary-Rose is a truly international individual having lived for two years in Zurich Switzerland and for more than a decade in various parts of the US (Princeton NJ, Albany NY, Philadelphia PA). Her professional experience includes a highly responsible position at Bell Canada in Montreal where, amongst other studies, she participated in a project to determine the telecommunication needs of disabled people and created a directory of available telecommunication aids. In each place she lived Mary-Rose volunteered in different capacities - helping in a halfway house, patterning a person with cerebral palsy, raising money for teens through a thrift shop, cooking food for homeless shelters, assisting in post op at a hospital. In 2008 Mary-Rose was awarded the City of Mississauga Civic Award of Recognition for her volunteer work. Mary-Rose has found time despite her busy schedule to raise a remarkable daughter. At ArrowCan, Mary-Rose is responsible for university relations and all market research activities. Paul Gill, Partner
|
Home Services Resources News About Us Contact Us Copyright © ArrowCan Partners 2005-2006 |
Paul
is a self-taught web designer who is currently completing his MD at McMaster
University after having completed an exceptional MS degree at the University
of Toronto through the department of Laboratory Medicine & Pathobiology
where he elucidated aspects of the mechanisms by which sonic hedgehog
signaling leads to kidney development. Paul's BSc was in a cooperative
education- based program in Biochemistry & Molecular Biology, at McMaster
University, For his bachelor’s thesis project, Paul worked on the
crystallization of a bifunctional kinase protein believed to be important
for antimicrobial resistance. Through the cooperative education program Paul
was able to work on constructing a S. coelicolor cDNA library at the
Antimicrobial Research Centre at McMaster University. Paul also spent a year
working in the field of breast cancer stems, studying the clonality of such
cells in causing cancer, and spent two years isolating a medicinal component
of a plant useful in destroying intestinal worms.